We are pleased to invite you to read the most viewed papers in 2023 in Cancers (ISSN: 2072-6694) on the topic of cancer pathophysiology. The paper list is as follows:

“Obesity and Cancer: A Current Overview of Epidemiology, Pathogenesis, Outcomes, and Management”
by Sukanya Pati, Wadeed Irfan, Ahmad Jameel, Shahid Ahmed and Rabia K. Shahid
Cancers 2023, 15(2), 485; https://doi.org/10.3390/cancers15020485
Available online: https://www.mdpi.com/2072-6694/15/2/485

“The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans”
by Nourhan Hassan, Janes Efing, Ludwig Kiesel, Gerd Bendas and Martin Götte
Cancers 2023, 15(5), 1524; https://doi.org/10.3390/cancers15051524
Available online: https://www.mdpi.com/2072-6694/15/5/1524

“How Warburg-Associated Lactic Acidosis Rewires Cancer Cell Energy Metabolism to Resist Glucose Deprivation”
by Zoé Daverio, Aneta Balcerczyk, Gilles J. P. Rautureau and Baptiste Panthu
Cancers 2023, 15(5), 1417; https://doi.org/10.3390/cancers15051417
Available online: https://www.mdpi.com/2072-6694/15/5/1417

“Advances in Imaging-Based Biomarkers in Renal Cell Carcinoma: A Critical Analysis of the Current Literature”
by Lina Posada Calderon, Lennert Eismann, Stephen W. Reese, Ed Reznik and Abraham Ari Hakimi
Cancers 2023, 15(2), 354; https://doi.org/10.3390/cancers15020354
Available online: https://www.mdpi.com/2072-6694/15/2/354

“Role of Natural and Synthetic Compounds in Modulating NRF2/KEAP1 Signaling Pathway in Prostate Cancer”
by Giovanni Tossetta, Sonia Fantone, Daniela Marzioni and Roberta Mazzucchelli
Cancers 2023, 15(11), 3037; https://doi.org/10.3390/cancers15113037
Available online: https://www.mdpi.com/2072-6694/15/11/3037

“Hyaluronan in the Cancer Cells Microenvironment”
by Evgenia Karousou, Arianna Parnigoni, Paola Moretto, Alberto Passi, Manuela Viola and Davide Vigetti
Cancers 2023, 15(3), 798; https://doi.org/10.3390/cancers15030798
Available online: https://www.mdpi.com/2072-6694/15/3/798

“p16 Immunohistochemical Expression as a Surrogate Assessment of CDKN2A Alteration in Gliomas Leading to Prognostic Significances”
by Lucas Geyer, Thibaut Wolf, Marie-Pierre Chenard, Helene Cebula, Roland Schott, Georges Noel, Eric Guerin, Erwan Pencreach, Damien Reita, Natacha Entz-Werlé et al.
Cancers 2023, 15(5), 1512; https://doi.org/10.3390/cancers15051512
Available online: https://www.mdpi.com/2072-6694/15/5/1512

“The Epigenesis of Salivary Glands Carcinoma: From Field Cancerization to Carcinogenesis”
by Norhafiza Mat Lazim, Anam Yousaf, Mai Abdel Haleem Abusalah, Sarina Sulong, Zul Izhar Mohd Ismail, Rohimah Mohamud, Hashem A. Abu-Harirah, Tareq Nayef AlRamadneh, Rosline Hassan and Baharudin Abdullah
Cancers 2023, 15(7), 2111; https://doi.org/10.3390/cancers15072111
Available online: https://www.mdpi.com/2072-6694/15/7/2111

“Incidental Diagnosis of Urothelial Bladder Cancer: Associations with Overall Survival”
by Hubert Kamecki, Małgorzata Dębowska, Jan Poleszczuk, Tomasz Demkow, Artur Przewor, Łukasz Nyk and Roman Sosnowski
Cancers 2023, 15(3), 668; https://doi.org/10.3390/cancers15030668
Available online: https://www.mdpi.com/2072-6694/15/3/668

“Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses”
by Nirmala Chandralega Kampan, Apriliana Ellya Ratna Kartikasari, Cyril Deceneux, Mutsa Tatenda Madondo, Orla M. McNally, Katie Louise Flanagan, Norhaslinda A. Aziz, Andrew N. Stephens, John Reynolds, Michael A. Quinn et al.
Cancers 2023, 15(3), 667; https://doi.org/10.3390/cancers15030667
Available online: https://www.mdpi.com/2072-6694/15/3/667

You are welcome to submit relevant papers to the journal Cancers. If you have any questions, you can contact the Editorial Office via cancers@mdpi.com.

Cancers Editorial Office